NCT07172646
- Conditions
- Dyslipidemias, Hyperlipidemias, Hyperlipoproteinemia (a), +4 more
- Locations
-
- Site 01 Beijing, Beijing Municipality, China
Clinical trial condition
Hyperlipoproteinemia (a)
Explore clinical trials studying Hyperlipoproteinemia (a). Study availability and eligibility vary by location and protocol.
2 public trials
1 recruiting study
Hyperlipoproteinemia (a) trial results
Active, Not Recruiting
An Open Label Extension (OLE) Study to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
NCT05900141
- Conditions
- Cardiovascular Diseases, Dyslipidemias, Hyperlipidemias, +5 more
- Locations
-
- Novartis Investigative Site Frankfurt am Main, Hesse, Germany
- Novartis Investigative Site Berlin, Germany
- Novartis Investigative Site Cloppenburg, Germany
- Novartis Investigative Site Dresden, Germany